Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
- 格式:pdf
- 大小:2.53 MB
- 文档页数:14
昆虫肠道菌群英语《The Gut Microbiota of Insects》Insects are the most diverse and numerous group of organisms on Earth, and their gastrointestinal tract is a crucial part of their biology. The gut microbiota of insects, comprised of a complex community of bacteria, fungi, and other microorganisms, plays a vital role in the overall health and physiology of their hosts.The gut microbiota of insects has been the subject of intense research in recent years, as scientists seek to understand its role in various aspects of insect biology. One of the most important functions of the gut microbiota is its involvement in digestion and nutrient processing. Many insects rely on their gut microbiota to break down complex molecules such as cellulose and lignin, which are abundant in their diets. In addition, the gut microbiota helps to synthesize essential nutrients that are lacking in the insect's diet, such as vitamins and amino acids.The gut microbiota also plays a key role in the immune system of insects, providing protection against pathogens and parasites. It can also influence the reproduction and development of insects, and even affect their behavior and ecological interactions. For example, the gut microbiota can impact the production of pheromones, which are important for mating and communication among insects.Furthermore, the gut microbiota of insects has significant implications for agriculture and pest management. Understanding the composition and function of the gut microbiota can lead to the development of novel methods for controlling pest insects, such as the use of probiotics or prebiotics to manipulate the gut microbiota and disrupt the insect's ability to feed and reproduce.In conclusion, the gut microbiota of insects is a fascinating and important area of study, with far-reaching implications for both basic research and practical applications. As we continue to unravel the complexities of the insect gut microbiota, we are likely to gain valuable insights into the biology of insects and discover new tools for managing insect populations in agricultural and ecological settings.。
我想发明可以治病的万能药水英语作文500字全文共3篇示例,供读者参考篇1I Want to Invent a Universal Cure-All PotionEver since I was a little kid, I've dreamed of becoming a scientist and making incredible discoveries that could help heal the world. Growing up, I was always fascinated by the natural world around me and how everything seemed to work in such an intricate, purposeful way. I loved learning about plants, animals, the human body, and the incredible complexities that made life on Earth possible. However, I was also acutely aware from a young age of how fragile life could be due to injury and disease.When I was eight years old, my beloved grandmother was diagnosed with an aggressive form of cancer. Seeing her once vibrant, energetic spirit slowly wither away as the cancer treatments took their toll was one of the most painful experiences of my life. Despite the best medical care available, the chemotherapy and radiation seemed to be just as destructive to her body as the disease itself. In the end, the treatments couldn't save her, and she passed away when I was ten years old.Her death shattered my family and left me wondering why, with all the incredible medical advances of the modern age, we still didn't have a way to simply cure diseases without causing such horrible side effects.That experience planted the seed of inspiration for my lifelong goal - to one day discover a universal cure that could treat any illness or injury without harmful side effects. A modern day panacea, if you will. A "cure-all" potion that could heal any malady by getting to the root cause and repairing it, whether viral, bacterial, genetic, cancerous, or anything in between. No more toxic chemotherapies that ravage the body. No more agonizing pain or slow withering away. Just a quick, effective cure that restored people to full health with limited discomfort. An ambitious goal for sure, but one that I believe is achievable through the wonderful world of science.Of course, developing such a miracle cure won't be easy. It will likely require an thorough understanding of biochemistry, genetics, microbiology, immunology, and multiple other disciplines all intersecting through an innovative new approach. But I'm convinced that solving this puzzle is possible through diligent research, out-of-the-box thinking, and harnessing thehealing power found naturally in plants, fungi, microbes, and other organisms.The natural world is an incredible pharmacy filled with a vast array of compounds that have evolved over billions of years to repair damage, fight infection, and keep diverse life forms healthy. Just look at how easily a tiny little plant can sprout from a seed and transform air, water and nutrients into a thriving organism. Or how plants have developed ingenious methods for warding off pests and pathogens without modern medicine. Or how fungi can quickly decompose matter and recycle it into reusable forms. Or how microbes can digest the toughest materials with incredibly efficient enzymes. The secrets to preventing and curing disease already exist in the natural world. We just have to study and harness them properly.That's why I've spent every summer since I was sixteen interning with researchers who are exploring the medicinal properties of plants, fungi, and microbes. I've worked in biotechnology labs expanding my knowledge of genetics and microbiology. I've also traveled to rainforests to learn from indigenous shamans about the therapeutic herbs and remedies they've used for millennia. With each new research experience, I can feel myself getting one step closer to that universal cure.My dream is to one day pioneer a discipline I call "arcano-therapeutic biomimicry" which will combine aspects of biochemistry, genetics, synthetic biology, herbology, mycology, microbiology and biomimetics. By taking the therapeutic compounds found in nature's most powerful botanicals, fungi and microbes, we could systematically study their molecular mechanisms for prevention, protection and healing. We could then biosynthesize and enhance those compounds to amplify their curative impacts. Finally, we could deliver those enhanced therapies in micro-doses through advanced bioengineering to eliminate toxicity while maximizing the healing benefits.Radical? Yes. Difficult? Absolutely. Impossible? I don't think so.Imagine being able to cure any injury or disease by simply taking a few micro-capsules derived from nature's own remedies, but turbocharged through biomimetic science. A severe bacterial infection? Cured in hours by supercharged antibiotics that don't disrupt your gut microbiome. Cancer? Eradicated by amicro-targeted therapy that instructs your own cells to heal themselves while leaving healthy cells unharmed. Genetic disorders, autoimmune diseases, neurological afflictions,age-related degeneration - all prevented, slowed or cured bycapitalizing on nature's intelligent design and adapting it to modern medicine. No more harsh side effects or slowly wasting away. Just targeted cures that work with your body's own systems to restore full health and vitality.That's the world I want to make possible through my life's work. A world where no one has to suffer the painful, undignified deterioration that my grandmother experienced. Where injuries and diseases can be healed at their core source rather than weighing down the body with toxins. A world with a universal remedy that can finally conquer the plagues that have haunted humanity since the dawn of our species.It may seem like an impossible pipe dream, but all great scientific advances once seemed that way before dedicated minds helped make them a reality. I truly believe that the secrets to curing humanity's ailments lie within the natural world that has been evolving exquisite therapies for billions of years. We just have to be bold enough to look there with open eyes and minds. I plan to spend the rest of my career doing just that in pursuit of the universal cure-all remedy. Because in my heart, I know it's possible and our world deserves nothing less.篇2I Want to Invent a Universal Cure-All MedicineEver since I was a little kid, I've dreamed of becoming a scientist and inventing something that could help millions of people around the world. My ultimate goal? To create a universal cure-all medicine that can treat any disease or illness. I know it sounds far-fetched, but hear me out!We've all had those days where we feel under the weather - maybe a nasty cold, a stomach bug, or something more serious. And what do we do? We go to the doctor, get some tests done, and they prescribe us some medicines based on our symptoms and diagnosis. But what if there was just one magic potion that could make us feel better no matter what ailed us?Imagine never having to suffer through the misery of being sick again. No more fevers, aches, pains, nausea, or any of the horrible feelings that come with illness. Just take a swig of the cure-all elixir andpoof- you're instantly back to 100% health. It would be absolutely life-changing!Of course, creating such a powerful medicine would be an enormous scientific challenge. You'd have to understand theroot causes and mechanisms of every single disease at a microscopic level. You'd need to analyze how different compounds interact with the body's cells, proteins, and biological systems. And then you'd have to develop a concoction capable of treating everything from the common cold to cancer to genetic disorders and beyond.It would require tireless research, experimentation, and probably more than a few accidental explosions in the lab (safety gear is a must!). We're talking years, if not decades, of work by the brightest scientific minds. Fortunately, I'm a dedicated student who loves hitting the books and solving complex problems.I know the odds of actually pulling this off are astronomically small. Realistically, even the greatest medical breakthroughs typically only scratch the surface by treating a small subset of conditions. But a kid can dream, right? The pursuit of knowledge and pushing the boundaries of what's possible is what drives scientific progress.Who knows, maybe one day we'll unlock the secrets of the human body and develop a true panacea for all that ails us. Or maybe my research will lead to other important medical advancements that dramatically improve quality of life. Eitherway, I'm determined to use my passion for science to help make the world a healthier, happier place. The universal cure-all may be a long shot, but it's a dream worth chasing!篇3I Want to Invent a Universal Medicine to Cure All DiseasesEver since I was a little kid, I've dreamed of becoming a scientist and inventing something that could help millions of people around the world. My biggest goal is to create a universal medicine that can cure any disease or illness. I know it sounds impossible, but I truly believe it can be done with enough hard work, research, and perseverance.Diseases have plagued humanity for centuries, cutting lives short and causing immense suffering. Despite the amazing medical advances we've made, there are still so many illnesses that have no cure. Cancer, Alzheimer's, HIV/AIDS, and countless others continue to devastate families everywhere. I can't imagine the heartbreak of watching a loved one suffer from an incurable disease. That's why I want to dedicate my life to finding a cure-all medicine.My idea for a universal cure is to create a highly adaptable drug that can target any virus, bacteria, or anomaly in the bodyand eliminate it. It would work kind of like how antibodies already work to fight infection, except this medicine would be a synthetic antibody that could morph to combat any disease it encountered. The possibilities seem endless!Of course, I know there would be massive challenges to overcome. Figuring out how to program a drug to identify and destroy any potential threat would be incredibly complex. There are likely thousands of obstacles I can't even foresee yet. But I'm committed to trying because the payoff would be worth it.If we could develop a cure-all medicine, it would revolutionize healthcare forever. No more chemotherapy, no more dialysis, no more watching people wither away from incurable illnesses. Everyone could live longer, healthier, happier lives without the constant threat of disease. It could eradicate so much suffering in the world.I realize my dream may sound naïve. There will always be new diseases emerging and challenges to overcome. But I have hope that if I dedicate myself to scientific research and work hard enough, I can make a dent. Even if I don't accomplish my final goal, contributing to the progress of medicine would be invaluable.In the meantime, I'm going to keep learning everything I can about biology, chemistry, biotechnology, and anything else that could help me get closer to my dream job as a medical researcher. I'll never stop being inspired by the chance to save millions of lives by inventing a groundbreaking universal cure. It's an audacious goal, but nobody can achieve the impossible without dreaming big first. I'm ready to dream big and change the world.。
北京市人大附中2021新高考英语外刊素材积累阅读写作提升25 肠道菌群如何影响身体的整体健康导读细菌通常被视为对健康有害的东西。
但事实并非如此,并非所有细菌都是有害的,有些细菌对健康状况很重要。
双语阅读From the moment we’re born, we acquire, and nurture an internal ecosystemof symbiotic bacteria and other microbes, trillions of them in all. In fact there are roughly as many microbial cells in our bodies as human cells. This thriving microbial world is called our microbiome.从我们出生的那一刻起,我们就具备了一个培养共生细菌和其他微生物,共计数万亿个微生物的内部生态系统。
事实上,我们体内的微生物细胞数量大约和人体细胞一样多。
这个兴旺发展的微生物世界被称为我们的微生物群落。
While some microbes can make us ill, we need our microbiome to survive. Combined, they are every bit as essential as our heart, our lungs or our brain. We have microbes living all over our skin and in every orifice of our bodies. But most of the microbiome is found in our gut. Our gut microbes are essential for digestion. They also help regulate hormones and they can boost our immune system.虽然有些微生物会让我们生病,但我们也需要它们来生存。
语言朋友(11)阅读理解For years we have been dieting strictly after the yearend overeating, afraid that when summer comes, the bigger size we have accumulated will betray how we ate.Now scientists say, it's a little bug that causes obesity(肥胖).As the holiday season with its abundant feasting arrives, millions of food lovers are keeping an eye on their figures.But scientists have found that weight gain is not about too much Christmas turkey or hot chocolates, but some bacteria in your guts(肠).Chinese scientists recently discovered a type of bacteria in guts that may be to blame for obesity.A research team led by Zhao Liping, a professor in Shanghai, has identified a precise link between a particular kind of bacteria and unusual weight gain.“The endotoxin(内毒素) released by the bacterium can activate(激活) a gene that helps produce fat.And it also deactivates a gene that consumes fat,〞 Zhao says.Scientists have long believed that microscopic organisms in the gut, microbiota, may play a very important role in weight gain, but they had never been able to prove it.In 2004, American microbiologist Jeffrey Gordon and his colleagues discovered a general link between obesity and gut microbiota in mice.While a link was believed to exist, proving it was another matter.“The list of diseases that they may play a role in is just growing and growing,〞says Lita Proctor, director of the US National Institutes of Health.“But the problem is that we're only able to look at associations and aren't yet able to conduct causeandeffect studies.〞In the clinical study, researchers found a growth of too muchendotoxinproducing bacteria, leading to 35 percent of the gut bacteria, in an obese patient whose initial weight was 175 kg.Based on this information, researchers tried to cure the patient by feeding him a specialized nutritional liquid food to decrease the bacteria in his guts to ignorable amounts.After 23 weeks, the patient lost 51.4 kg, with his fatty liver disease having almost disappeared.解题导语:科学家们发现肥胖与肠道里的一种细菌有关。
牛人对细菌的看法英语作文The Perception of Bacteria from the Perspective of a Genius。
Bacteria, the tiny and ubiquitous creatures that exist in almost every corner of our world, have been a topic of fascination and study for centuries. While many people view bacteria as harmful and dangerous, one genius has a different perspective on these microorganisms.According to this individual, who is widely regarded as one of the greatest scientific minds of our time, bacteria are not only harmless but also essential to life on earth. He believes that bacteria play a crucial role in maintaining the balance of our planet's ecosystems and that they offer many benefits to human health.One of the key insights that this genius has provided regarding bacteria is that they are not all the same. In fact, there are many different types of bacteria, each withits own unique characteristics and properties. Some bacteria are harmful to humans and can cause disease, while others are beneficial and can help us fight off infections and maintain our health.Moreover, this genius has also pointed out that bacteria are incredibly adaptable and resilient. They can survive in a wide range of environments, from the depths of the ocean to the harsh conditions of outer space. They can also evolve quickly in response to changes in their environment, which makes them a formidable opponent in the fight against infectious diseases.Despite their many benefits, however, bacteria are often viewed with suspicion and fear. Many people associate bacteria with illness and disease, and they go to great lengths to avoid contact with these microorganisms. This is a mistake, according to the genius, who argues that we should embrace bacteria and learn to live in harmony with them.One way that we can do this is by taking a moreholistic approach to health and wellness. Rather than relying solely on antibiotics and other medical treatments, we should focus on building up our immune systems and promoting the growth of beneficial bacteria in our bodies. This can be achieved through a healthy diet, regular exercise, and exposure to natural environments.In conclusion, the perception of bacteria from the perspective of a genius is one of respect and admiration. Rather than viewing these microorganisms as a threat, he sees them as an essential part of the world around us. By embracing bacteria and learning to live in harmony with them, we can unlock their many benefits and improve our health and wellbeing.。
Microbial Ecology of the Gut and GutHealthThe microbial ecology of the gut plays a crucial role in maintaining gut health. The gut microbiome consists of trillions of bacteria, viruses, fungi, and other microorganisms that reside in the gastrointestinal tract. These microbesplay a vital role in digestion, nutrient absorption, immune system regulation, and overall health. When the balance of these microbes is disrupted, it can lead to various health problems, including gastrointestinal disorders, obesity, autoimmune diseases, and mental health issues. One perspective to consider is the importance of a diverse gut microbiome. A diverse microbiome is associated with betteroverall health and a lower risk of disease. A diet rich in fiber, fruits, vegetables, and fermented foods can help promote microbial diversity in the gut. On the other hand, a diet high in processed foods, sugar, and unhealthy fats can lead to a less diverse and less healthy microbiome. This highlights the importance of dietary choices in maintaining gut health. Another perspective to consider is the role of antibiotics in disrupting the gut microbiome. Antibiotics are commonly prescribed to treat bacterial infections, but they can also kill off beneficial bacteria in the gut. This disruption can lead to an overgrowth of harmful bacteria, which can cause digestive issues and other health problems. It is important for healthcare providers to consider the potential impact of antibiotics on the gut microbiome and to prescribe them judiciously. Stress is another factor that can impact the gut microbiome. Chronic stress can lead to changes in gut motility, blood flow, and immune function, which can alter the composition of the gut microbiome. This can contribute to gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Finding ways to manage stress, such as through mindfulness practices, exercise, and social support, can help support a healthy gut microbiome. The gut-brain axis is a bidirectional communication system between the gut and the brain that plays a key role in gut health. The gut microbiome produces neurotransmitters and other signaling molecules that can influence brain function and behavior. Conversely, the braincan also impact the gut microbiome through stress and other factors. Thisconnection highlights the importance of considering mental health and emotional well-being in maintaining gut health. Probiotics and prebiotics are two key components of gut health that can help support a healthy microbiome. Probiotics are live bacteria that can provide health benefits when consumed in adequate amounts. They can help restore balance to the gut microbiome and support digestion and immune function. Prebiotics are a type of fiber that feed the beneficial bacteria in the gut, helping them thrive and multiply. Including probiotic-rich foods like yogurt, kefir, and sauerkraut, as well as prebiotic-rich foods like onions, garlic, and bananas, in the diet can help support gut health. In conclusion, the microbial ecology of the gut plays a vital role in maintaining overall health and well-being. By considering factors such as diet, antibiotics, stress, the gut-brain axis, and probiotics/prebiotics, we can support a healthy gut microbiome and promote optimal gut health. Making informed choices about our lifestyle and dietary habits can have a significant impact on the health of our gut microbiome and, in turn, our overall health.。
The genomics of probiotic intestinal microorganismsSeppo Salminen1 , Jussi Nurmi2 and Miguel Gueimonde1(1) Functional Foods Forum, University of Turku, FIN-20014 Turku, Finland(2) Department of Biotechnology, University of Turku, FIN-20014 Turku, FinlandSeppo SalminenEmail: *********************Published online: 29 June 2005AbstractAn intestinal population of beneficial commensal microorganisms helps maintain human health, and some of these bacteria have been found to significantly reduce the risk of gut-associated disease and to alleviate disease symptoms. The genomic characterization of probiotic bacteria and other commensal intestinal bacteria that is now under way will help to deepen our understanding of their beneficial effects.While the sequencing of the human genome [1, 2] has increased ourunderstanding of the role of genetic factors in health and disease, each human being harbors many more genes than those in their own genome. These belong to our commensal and symbiotic intestinal microorganisms - our intestinal 'microbiome' - which play an important role in maintaining human health and well-being. A more appropriate image of ourselves would be drawn if the genomes of our intestinal microbiota were taken into account. The microbiome may contain more than 100 times the number of genes in the human genome [3] and provides many functions that humans have thus not needed to develop themselves. The indigenous intestinal microbiota provides a barrier against pathogenic bacteria and other harmful food components [4–6]. It has also been shown to have a direct impact on the morphology of the gut [7], and many intestinal diseases can be linked to disturbances in the intestinal microbial population [8].The indigenous microbiota of an infant's gastrointestinal tract is originally created through contact with the diverse microbiota of the parents and the immediate environment. During breast feeding, initial microbial colonization is enhanced by galacto-oligosaccharides in breast milk and contact with the skin microbiota of the mother. This early colonization process directs the microbial succession until weaning and forms the basis for a healthy microbiota. The viable microbes in the adultintestine outnumber the cells in the human body tenfold, and the composition of this microbial population throughout life is unique to each human being. During adulthood and aging the composition and diversity of the microbiota can vary as a result of disease and the genetic background of the individual.Current research into the intestinal microbiome is focused on obtaining genomic data from important intestinal commensals and from probiotics, microorganisms that appear to actively promote health. This genomic information indicates that gut commensals not only derive food and other growth factors from the intestinal contents but also influence their human hosts by providing maturational signals for the developing infant and child, as well as providing signals that can lead to an alteration in the barrier mechanisms of the gut. It has been reported that colonization by particular bacteria has a major role in rapidly providing humans with energy from their food [9]. For example, the intestinal commensal Bacteroides thetaiotaomicron has been shown to have a major role in this process, and whole-genome transcriptional profiling of the bacterium has shown that specific diets can be associated with selective upregulation of bacterial genes that facilitate delivery of products of carbohydrate breakdown to the host's energy metabolism [10, 11]. Key microbial groups in the intestinal microbiota are highly flexible in adapting to changes in diet, and thus detailed prediction of their actions and effects may be difficult. Although genomic studies have revealed important details about the impact of the intestinal microbiota on specific processes [3, 11–14], the effects of species composition and microbial diversity and their potential compensatory functions are still not understood.Probiotics and healthA probiotic has been defined by a working group of the International Life Sciences Institute Europe (ILSI Europe) as "a viable microbial food supplement which beneficially influences the health of the host" [15]. Probiotics are usually members of the healthy gut microbiota and their addition can assist in returning a disturbed microbiota to its normal beneficial composition. The ILSI definition implies that safety and efficacy must be scientifically demonstrated for each new probiotic strain and product. Criteria for selecting probiotics that are specific for a desired target have been developed, but general criteria that must be satisfied include the ability to adhere to intestinal mucosa and tolerance of acid and bile. Such criteria have proved useful but cumbersome in current selection processes, as there are several adherence mechanisms and they influence gene upregulation differently in the host. Therefore, two different adhesion studies need to be conducted on each strain and theirpredictive value for specific functions is not always good or optimal. Demonstration of the effects of probiotics on health includes research on mechanisms and clinical intervention studies with human subjects belonging to target groups.The revelation of the human genome sequence has increased our understanding of the genetic deviations that lead to or predispose to gastrointestinal disease as well as to diseases associated with the gut, such as food allergies. In 1995, the first genome of a free-living organism, the bacterium Haemophilus influenzae, was sequenced [16]. Since then, over 200 bacterial genome sequences, mainly of pathogenic microorganisms, have been completed. The first genome of a mammalian lactic-acid bacterium, that of Lactococcus lactis, a microorganism of great industrial interest, was completed in 2001 [17]. More recently, the genomes of numerous other lactic-acid bacteria [18], bifidobacteria [12] and other intestinal microorganisms [13, 19, 20] have been sequenced, and others are under way [21]. Table 1lists the probiotic bacteria that have been sequenced. These great breakthroughs have demonstrated that evolution has adapted both microbes and humans to their current state of cohabitation, or even symbiosis, which is beneficial to both parties and facilitates a healthy and relatively stable but adaptable gut environment.Table 1Lessons from genomesLactic-acid bacteria and bifidobacteria can act as biomarkers of gut health by giving early warning of aberrations that represent a risk of specific gut diseases. Only a few members of the genera Lactobacillus and Bifidobacterium, two genera that provide many probiotics, have been completely sequenced. The key issue for the microbiota, for probiotics, and for their human hosts is the flexibility of the microorganisms in coping with a changeable local environment and microenvironments.This flexibility is emphasized in the completed genomes of intestinal and probiotic microorganisms. The complete genome sequence of the probiotic Lactobacillus acidophilus NCFM has recently been published by Altermann et al. [22]. The genome is relatively small and the bacterium appears to be unable to synthesize several amino acids, vitamins and cofactors. Italso encodes a number of permeases, glycolases and peptidases for rapid uptake and utilization of sugars and amino acids from the human intestine, especially the upper gastrointestinal tract. The authors also report a number of cell-surface proteins, such as mucus- and fibronectin-binding proteins, that enable this strain to adhere to the intestinal epithelium and to exchange signals with the intestinal immune system. Flexibility is guaranteed by a number of regulatory systems, including several transcriptional regulators, six PurR-type repressors and ninetwo-component systems, and by a variety of sugar transporters. The genome of another probiotic, Lactobacillus johnsonii [23], also lacks some genes involved in the synthesis of amino acids, purine nucleotides and numerous cofactors, but contains numerous peptidases, amino-acid permeases and other transporters, indicating a strong dependence on the host.The presence of bile-salt hydrolases and transporters in these bacteria indicates an adaptation to the upper gastrointestinal tract [23], enabling the bacteria to survive the acidic and bile-rich environments of the stomach and small intestine. In this regard, bile-salt hydrolases have been found in most of the sequenced genomes of bifidobacteria and lactic-acid bacteria [24], and these enzymes can have a significant impact on bacterial survival. Another lactic-acid bacterium, Lactobacillus plantarum WCFS1, also contains a large number of genes related to carbohydrate transport and utilization, and has genes for the production of exopolysaccharides and antimicrobial agents [18], indicating a good adaptation to a variety of environments, including the human small intestine [14]. In general, flexibility and adaptability are reflected by a large number of regulatory and transport functions.Microorganisms that inhabit the human colon, such as B. thetaiotaomicron and Bifidobacterium longum [12], have a great number of genes devoted to oligosaccharide transport and metabolism, indicating adaptation to life in the large intestine and differentiating them from, for example, L. johnsonii [23]. Genomic research has also provided initial information on the relationship between components of the diet and intestinal microorganisms. The genome of B. longum [12] suggests the ability to scan for nutrient availability in the lower gastrointestinal tract in human infants. This strain is adapted to utilizing the oligosaccharides in human milk along with intestinal mucins that are available in the colon of breast-fed infants. On the other hand, the genome of L. acidophilus has a gene cluster related to the metabolism of fructo-oligosaccharides, carbohydrates that are commonly used as prebiotics, or substrates to肠道微生物益生菌的基因组学塞波萨米宁,尤西鲁米和米格尔哥尔摩得(1)功能性食品论坛,图尔库大学,FIN-20014芬兰图尔库(2)土尔库大学生物技术系,FIN-20014芬兰图尔库塞波萨米宁电子邮件:seppo.salminen utu.fi线上发表于2005年6月29日摘要肠道有益的共生微生物有助于维护人体健康,一些这些细菌被发现显着降低肠道疾病的风险和减轻疾病的症状。
细菌在人体的旅行英语作文英文回答:Bacteria in the Human Body: A Journey.Bacteria are ubiquitous organisms that play a vitalrole in the human body's health and well-being. These tiny microbes colonize various parts of our bodies, including the skin, mouth, gut, and respiratory tract. Their presence is not always harmful; in fact, many bacterial species are essential for maintaining homeostasis and protecting against infections.The Skin: A Diverse Microbial Landscape.The skin, the body's largest organ, is home to a vast array of bacterial species. These microbes form a complex ecosystem that protects the body from pathogens by competing for resources and producing antimicrobial substances. The skin's resident bacteria also contribute toskin health by synthesizing vitamins and fatty acids.The Mouth: A Bacterial Haven.The mouth is a teeming microcosm of bacterial life. Over 700 different species reside in the oral cavity, forming a complex community that plays a crucial role in tooth decay, gum disease, and overall oral health. The balance between beneficial and harmful bacteria isessential for maintaining a healthy oral ecosystem.The Gut: A Microbial Powerhouse.The human gut is home to trillions of bacteria, comprising a complex and diverse microbiota. These microbes play a central role in digestion, nutrient absorption, and immune function. The gut microbiota is also involved in metabolic processes, such as vitamin synthesis and the regulation of cholesterol levels.The Respiratory Tract: A Defense Against Invaders.The respiratory tract, including the nose and lungs, is constantly exposed to potential pathogens. Resident bacteria in these regions serve as a first line of defense against infection. They compete with invading microorganisms for space and nutrients, helping to prevent colonization and subsequent disease.Bacterial Infections.While many bacteria are harmless or even beneficial, certain species can cause infections. These infections can range from minor skin irritations to life-threatening conditions. Common bacterial infections include pneumonia, urinary tract infections, and sepsis. Antibiotics are often used to treat bacterial infections, but their overuse can contribute to antibiotic resistance.Antibiotic Resistance: A Growing Concern.Antibiotic resistance is a major public health threat that arises when bacteria evolve to become resistant to the drugs designed to kill them. This resistance can make itdifficult or impossible to treat bacterial infections, leading to prolonged illness, disability, and even death. Overuse and misuse of antibiotics are primary drivers of antibiotic resistance.Conclusion.Bacteria are an integral part of the human body, playing essential roles in health and disease. Understanding the diverse roles of bacteria and thedelicate balance between beneficial and harmful species is crucial for maintaining a healthy microbiome and preventing infections. Responsible use of antibiotics and promoting a healthy lifestyle can help preserve a balanced and beneficial bacterial ecosystem within the human body.中文回答:细菌在人体内的旅行。
Article Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin BiosynthesisGraphical AbstractHighlightsd Gut microbes regulate levels of5-HT in the colon and blood d Spore-forming bacteria modulate metabolites that promotecolon5-HT biosynthesisd Microbiota-dependent changes in5-HT impact GI motilityand hemostasisd Altering the microbiota could improve5-HT-related diseasesymptoms AuthorsJessica M.Yano,Kristie Yu,...,Sarkis K.Mazmanian,Elaine Y.HsiaoCorrespondenceehsiao@In BriefIndigenous spore-forming microbes from the gut microbiota produce metabolites that promote host serotonin biosynthesis in the gastrointestinal tract and impact gastrointestinal motility andhemostasis. Yano et al.,2015,Cell161,264–276April9,2015ª2015Elsevier Inc./10.1016/j.cell.2015.02.047Article Indigenous Bacteria from the Gut MicrobiotaRegulate Host Serotonin BiosynthesisJessica M.Yano,1Kristie Yu,1Gregory P.Donaldson,1Gauri G.Shastri,1Phoebe Ann,1Liang Ma,2Cathryn R.Nagler,3 Rustem F.Ismagilov,2Sarkis K.Mazmanian,1and Elaine Y.Hsiao1,*1Division of Biology and Biological Engineering,California Institute of Technology,Pasadena,CA91125,USA2Division of Chemistry and Chemical Engineering,California Institute of Technology,Pasadena,CA91125,USA3Department of Pathology and Department of Medicine,University of Chicago,Chicago,IL60637,USA*Correspondence:ehsiao@/10.1016/j.cell.2015.02.047SUMMARYThe gastrointestinal(GI)tract contains much of the body’s serotonin(5-hydroxytryptamine,5-HT), but mechanisms controlling the metabolism of gut-derived5-HT remain unclear.Here,we demonstrate that the microbiota plays a critical role in regulating host5-HT.Indigenous spore-forming bacteria(Sp) from the mouse and human microbiota promote5-HT biosynthesis from colonic enterochromaffin cells (ECs),which supply5-HT to the mucosa,lumen,and circulating platelets.Importantly,microbiota-depen-dent effects on gut5-HT significantly impact host physiology,modulating GI motility and platelet func-tion.We identify select fecal metabolites that are increased by Sp and that elevate5-HT in chromaffin cell cultures,suggesting direct metabolic signaling of gut microbes to ECs.Furthermore,elevating luminal concentrations of particular microbial metab-olites increases colonic and blood5-HT in germ-free mice.Altogether,thesefindings demonstrate that Sp are important modulators of host5-HT and further highlight a key role for host-microbiota interactions in regulating fundamental5-HT-related biological processes.INTRODUCTIONIn addition to its role as a brain neurotransmitter,the monoamine serotonin(5-hydroxytryptamine[5-HT])is an important regulato-ry factor in the gastrointestinal(GI)tract and other organ sys-tems.More than90%of the body’s5-HT is synthesized in the gut,where5-HT activates as many as14different5-HT receptor subtypes(Gershon and Tack,2007)located on enterocytes (Hoffman et al.,2012),enteric neurons(Mawe and Hoffman, 2013),and immune cells(Baganz and Blakely,2013).In addition, circulating platelets sequester5-HT from the GI tract,releasing it to promote hemostasis and distributing it to various body sites (Amireault et al.,2013).As such,gut-derived5-HT regulates diverse functions,including enteric motor and secretory reflexes (Gershon and Tack,2007),platelet aggregation(Mercado et al.,2013),immune responses(Baganz and Blakely,2013),and bone development(Chabbi-Achengli et al.,2012;Yadav et al.,2008), and cardiac function(Coˆte´et al.,2003).Furthermore,dysregula-tion of peripheral5-HT is implicated in the pathogenesis of several diseases,including irritable bowel syndrome(IBS)(Stasi et al.,2014),cardiovascular disease(Ramage and Villalo´n,2008), and osteoporosis(Ducy and Karsenty,2010).The molecular mechanisms controlling the metabolism of gut5-HT remain unclear.In the GI tract,5-HT is synthesized by specialized endocrine cells,called enterochromaffin cells (ECs),as well as mucosal mast cells and myenteric neurons (Gershon and Tack,2007),but the functions of these different pools of gut5-HT are incompletely understood.In addition, two different isoenzymes of tryptophan hydroxylase(Tph), Tph1and Tph2,mediate non-neuronal versus neuronal5-HT biosynthesis(Walther et al.,2003),but little is known regarding the endogenous signals that regulate Tph expression and activity.Mammals are colonized by a vast and diverse collection of microbes that critically influences health and disease.Recent studies highlight a role for the microbiota in regulating blood 5-HT levels,wherein serum concentrations of5-HT are substan-tially reduced in mice reared in the absence of microbial coloni-zation(germ-free[GF]),compared to conventionally-colonized (specific pathogen-free[SPF])controls(Sjo¨gren et al.,2012;Wik-off et al.,2009).In addition,intestinal ECs are morphologically larger in GF versus SPF rats(Uribe et al.,1994),which suggests that microbes could impact the development and/or function of 5-HT-producing cells.Interestingly,some species of bacteria grown in culture can produce5-HT(Tsavkelova et al.,2006), raising the question of whether indigenous members of the mi-crobiota contribute to host5-HT levels through de novo synthe-sis.Based on this emerging link between the microbiota and serum5-HT concentrations,we aimed to determine how path-ways of5-HT metabolism are affected by the gut microbiota, to identify specific microbial communities and factors involved in conferring serotonergic effects,and to evaluate how microbial modulation of peripheral5-HT impacts host physiology. Here,we show that the microbiota promotes5-HT biosyn-thesis from colonic ECs in a postnatally inducible and reversible manner.Spore-forming microbes(Sp)from the healthy mouse and human microbiota sufficiently mediate microbial effects on serum,colon,and fecal5-HT levels.We further explore potential host-microbial interactions that regulate peripheral5-HTby264Cell161,264–276,April9,2015ª2015Elsevier Inc.surveying microbial influences on the fecal metabolome.We find that particular microbial metabolites are elevated by Sp and likely signal directly to colonic ECs to promote 5-HT biosyn-thesis.Importantly,microbiota-mediated changes in colonic 5-HT regulate GI motility and hemostasis in the host,suggesting that targeting the microbiota can serve as a tractable approach for modulating peripheral 5-HT bioavailability and treating 5-HT-related disease symptoms.RESULTSThe Gut Microbiota Modulates Host PeripheralSerotonin LevelsAdult GF mice display deficient serum (Sjo¨gren et al.,2012;Wik-off et al.,2009)(Figure 1A)and plasma (Figure S1A)5-HT con-centrations compared to SPF controls,but the cellular sources of this disruption are undefined.Consistent with the understand-ing that much of the body’s 5-HT derives from the GI tract,we find that GF mice exhibit significantly decreased levels of colonic and fecal 5-HT compared to SPF controls (Figures 1B and S1A;Table S1).This deficit in 5-HT is observed broadly across the distal,medial and proximal colon (Figure S1D),but not in the small intestine (Figures S1A,S2A,and S2B),suggesting a specific role for the microbiota in regulating colonic 5-HT.Decreased levels of 5-HT are localized to colonic chromogranin A-positive (CgA+)enterochromaffin cells (ECs)(Figure 2),and not to small intestinal ECs (Figures S2A and S2B).Low 5-HT signal is seen in both GF and SPF colonic mast cells and entericFigure 1.The Gut Microbiota Modulates Host Peripheral Serotonin Levels(A)Levels of serum 5-HT.Data are normalized to serum 5-HT in SPF mice (n =8–13).(B)Levels of colon 5-HT relative to total protein.Data are normalized to colon 5-HT relative to total protein in SPF mice (n =8–13).(C)Colonic expression of TPH1relative to GAPDH .Data are normalized to expression levels in SPF mice (n =4).(D)Colonic expression of SLC6A4relative to GAPDH .Data are normalized to expression levels in SPF mice (n =4).Data are presented as mean ±SEM.*p <0.05,**p <0.01,***p <0.001.n.s.,not statistically sig-nificant;SPF,specific pathogen-free (convention-ally-colonized);GF,germ-free;CONV.,SPF con-ventionalized;ABX,antibiotic-treated;VEH,vehicle (water)-treated.See also Figure S1.neurons (Figure 2A),which are minor pro-ducers of 5-HT (Gershon and Tack,2007).There is no difference betweenadult GF and SPF mice in the abundanceof CgA+ECs (Figure 2C),suggesting thatdecreases in colon 5-HT result fromabnormal 5-HT metabolism rather than impaired development of ECs.To identify the specific steps of 5-HT metabolism that are affected by the micro-biota,key intermediates of the 5-HT pathway were assessed in colons from GF versus SPF mice.We find that GF colons exhibitdecreased expression of TPH1(Figures 1C and S1D)(Sjo¨gren et al.,2012),the rate-limiting enzyme for 5-HT biosynthesis in ECs,but no difference in expression of enzymes involved in 5-HT packaging,release and catabolism (Figure S1C).GF mice also display elevated colonic expression of the 5-HT transporterSLC6A4(Figures 1D and S1E)(Sjo¨gren et al.,2012),synthesized broadly by enterocytes to enable 5-HT uptake (Wade et al.,1996).This could reflect a compensatory response to deficient 5-HT synthesis by host ECs,based on the finding that chemical Tph inhibition modulates SLC6A4expression (Figures S2C and S2D).There is no difference between GF and SPF mice in colonic expression of neural-specific isoforms of 5-HT enzymes (Fig-ure S1F),consistent with data showing no apparent difference in 5-HT-specific staining in enteric neurons (Figure 2).Despite deficient levels of colon,fecal,and serum 5-HT (Figures 1A,1B,and S1A;Table S1),GF mice exhibit significantly increased levels of the Tph substrate,tryptophan (Trp),in both feces (TableS1)and serum (Sjo¨gren et al.,2012;Wikoff et al.,2009),suggest-ing that primary disruptions in host TPH1expression result in Trp accumulation.Oral supplementation of GF mice with the Tph product,5-hydroxytryptophan (5-HTP),sufficiently ameliorates deficits in colon and serum 5-HT,whereas supplementation with the Tph substrate Trp has no restorative effect (Figures S1G–S1I).Collectively,these data support the notion that the mi-crobiota promotes 5-HT biosynthesis by elevating TPH1expres-sion in colonic ECs.Cell 161,264–276,April 9,2015ª2015Elsevier Inc.265To confirm that deficient 5-HT levels in GF mice are micro-biota-dependent and further determine whether effects are age-dependent,GF mice were conventionalized with an SPF microbiota at birth (postnatal day [P]0),weaning (P21),or early adulthood (P42)and then evaluated at P56for levels of 5-HT and expression of 5-HT-related genes.GF mice conventional-ized at each age with an SPF microbiota exhibit restored serum (Figure 1A)and colon (Figure 1B)5-HT levels,with more pronounced effects seen at earlier ages of colonization.Colonic expression of TPH1and SLC6A4is similarly corrected by postnatal conventionalization of GF mice (Figures 1C and 1D),with more substantial changes from P0conventionaliza-tion.Increases in 5-HT are localized to colonic ECs (Figure 2).These findings indicate that postnatal reconstitution of the gut microbiota can correct the 5-HT deficiency seen in GF mice and further suggest that gut microbes exert a continuous ef-fect on 5-HT synthesis by modulating EC function.Overall,we demonstrate that microbiota-mediated elevation of host 5-HT is postnatally inducible,persistent from the time ofconventionalization and not dependent on the timing of host development.To assess the reversibility of microbial effects on host 5-HT metabolism,we depleted the gut microbiota in SPF mice via bi-daily antibiotic treatment beginning on P0,P21,or P42and until P56.Treatment of P42SPF mice with a cocktail of ampi-cillin,vancomycin,neomycin,and metronidazole (Reikvam et al.,2011)sufficiently recapitulates GF-associated deficits in serum and colon 5-HT and alterations in host colonic TPH1and SLC6A4expression (Figures 1and 2).Interestingly,P0and P21antibiotic treatment also induces GF-related deficits in colonic 5-HT,but the effects on serum 5-HT are more pro-nounced when administered at P42,compared to P0and P21(Figure 1),suggesting potential confounding effects of early life or prolonged antibiotic treatment on microbiota-mediated mod-ulation of peripheral 5-HT.Antibiotics can elicit several direct ef-fects on host cells (Shimizu et al.,2003;Westphal et al.,1994),which may underlie differences between P0treatment and GF status.That P42antibiotic treatment of SPF mice resultsinSPF GF P21P42P21P42GF GF0.00.51.01.55-H T +c ells/Cg A+cel lsGF+CONV.SPF+ABX *********+Sp.+Sp.+PCPA****SPF GF P21P42P21P42GFGF200040006000800010000C g A + c e l l s / m m 2GF+CONV.SPF+ABX p=0.0814+Sp.+Sp.+PCPA2000400060005-H T + c e l l s / m m 2GF+CONV.SPF+ABX +Sp.********p=0.0624+Sp.+PCPA***A BCDFigure 2.Indigenous Spore-Forming Bacteria Increase 5-HT Levels in Colon Enterochromaffin Cells(A)Representative images of colons stained for chromogranin A (CgA)(left),5-HT (center),and merged (right).Arrows indicate CgA-positive cells that lack 5-HTstaining (n =3–7mice/group).(B)Quantitation of 5-HT+cell number per area of colonic epithelial tissue (n =3–7mice/group).(C)Quantitation of CgA+cell number per area of colonic epithelial tissue (n =3–7mice/group).(D)Ratio of 5-HT+cells/CgA+cells per area of colonic epithelial tissue (n =3–7mice/group).Data are presented as mean ±SEM.*p <0.05,**p <0.01,***p <0.001,****p <0.0001.SPF,specific pathogen-free (conventionally-colonized);GF,germ-free;CONV.,SPF conventionalized;ABX,antibiotic-treated;Sp,spore-forming bacteria;PCPA,para-chlorophenylalanine.See also Figure S2.266Cell 161,264–276,April 9,2015ª2015Elsevier Inc.5-HT phenotypes analogous to those seen in GF mice demon-strates that microbiota effects on host 5-HT can be abrogated postnatally and further supports the plasticity of 5-HT modula-tion by indigenous gut microbes.Altogether,these data indicate that the gut microbiota plays a key role in raising levels of colon and serum 5-HT,by promoting 5-HT in colonic ECs in an induc-ible and reversible manner.Indigenous Spore-Forming Microbes Promote Host Serotonin BiosynthesisIn light of our finding that 5-HT levels are decreased in colons but not small intestines of GF mice compared to SPF controls,we hypothesized that specific subsets of gut microbes are responsible for affecting host 5-HT pathways.Mice mono-colonized with Bacteroides fragilis or Segmented Filamentous Bacteria (SFB)display deficits in serum 5-HT that are compara-ble to those seen in GF mice (Figure 3A).Moreover,postnatal colonization (P21)with Bacteroides uniformis ,altered Schae-dler flora (ASF),an eight-microbe consortium known to correct gross intestinal pathology in GF mice (Dewhirst et al.,1999),or with cultured Bacteroides spp.from the SPF mouse microbiota,has no significant effect on the 5-HT deficiency seen in GF mice (Figures 3A and 3B).Interestingly,however,GF mice colonized at P42with indigenous spore-forming microbes from the mouse SPF microbiota (Sp),known to be dominated by Clos-tridial species (Atarashi et al.,2013;Stefka et al.,2014)(Table S2),exhibit complete restoration of serum and colon 5-HT to levels observed in SPF mice (Figures 3A and 3B).Consistent with this,Sp colonization of GF mice increases 5-HT staining colocalized to CgA+ECs (Figure 2),elevates host colonic TPH1expression (Figure 3D)and decreases SLC6A4expres-sion (Figure 3E)toward levels seen in SPF mice.Improvements in serum 5-HT are observed within 2days after inoculation of GF mice with Sp (Figure S2E)and do not correlate with amelio-ration of abnormal cecal weight (Figure S2F).Importantly,Sp also elevates colonic 5-HT in Rag1knockout mice (Figure S2G),which lack adaptive immune cells,indicating that the effects of Sp on gut 5-HT are not dependent on Sp-mediated regulatory T cell induction (Stefka et al.,2014).Notably,the 5-HT-promot-ing effects of Sp are recapitulated by colonization of GF mice with spore-forming microbes from the healthy human colonic microbiota (hSp)(Figure S3),suggesting that the serotonergic function of this community is conserved across mice and humans.To determine whether the effects of Sp on host 5-HT depend on colonic Tph activity,we colonized GF mice with Sp on P42and then administered the Tph inhibitor para-chloropheny-lalanine (PCPA)intrarectally twice daily for 3days prior to 5-HT assessments on P56(Liu et al.,2008).Intrarectal injection of PCPA sufficiently blocks the ability of Sp to elevate colon and serum 5-HT levels (Figures 3C and S2C),as well as Sp-medi-ated increases in 5-HT staining in ECs (Figure 2).Similar effects of PCPA treatment on blocking increases in colon 5-HT,serum 5-HT,and 5-HT staining in colonic ECs are seen in GF mice colonized with hSp (Figure S3).Interestingly,inhibiting Tph activity with PCPA results in a compensatory increase in colonic TPH1and decrease in SLC6A4(Figures 3D and S2D)expression in Sp-colonized mice,supporting the notionthatSPFSPF GF GF GF0.00.51.01.52.0T p h 1/G A P D H m R N Ap=0.0517***n.s.+Sp.+Sp.PCPA:-+-+-SPF GF GF BF GF2465-H T (f o l d c h a n g e )+ Sp.*****+ Bd.c o l o n 5-H T(n o r m a l i z e d )SPF SPF GF GF GF2040605-H T (n g /g p r o t e i n )*********n.s.+Sp.+Sp.PCPA:-+-+-**0.00.51.01.52.05-H T (n o r m a l i z e d )*******SPF GFGF+conv.SPF+abx B. fragilis SFB GF+ASF GF+Sp.GF+B. uniformis GF+Bd.n.s.BACDs e r u m 5-H T(n o r m a l i z e d )Figure 3.Indigenous Spore-Forming Bacte-ria Induce Colon 5-HT Biosynthesis and Sys-temic 5-HT Bioavailability(A)Levels of serum 5-HT.Data are normalized to serum 5-HT levels in SPF mice.SPF,n =13;GF,n =17;GF+conv,P21conventionalization,n =4;SPF+Abx,P42antibiotic treatment,n =7;B.fragilis monoassociation (BF),n =6;SFB,Segmented Filamentous Bacteria monoassociation,n =4;ASF,Altered Schaedler Flora P21colonization,n =4;Sp,spore-forming bacteria,P21colonization,n =4;B.uniformis P21colonization,n =4;Bd,Bacter-oides consortium,n =3.(B)Levels of colon 5-HT relative to total protein.Data are normalized to colon 5-HT relative to total protein in SPF mice (n =5–15).(C)Levels of colon 5-HT relative to total protein after intrarectal treatment with the Tph inhibitor,PCPA,or vehicle (n =4).(D)Colonic expression of TPH1relative to GAPDH .Data are normalized to expression levels in SPF mice (n =3).Data are presented as mean ±SEM.*p <0.05,**p <0.01,***p <0.001,****p <0.0001.n.s.,not statistically significant;SPF,specific pathogen-free (conventionally-colonized);GF,germ-free;Sp,spore-forming bacteria;PCPA,para-chlor-ophenylalanine.See also Figure S3.Cell 161,264–276,April 9,2015ª2015Elsevier Inc.267microbiota-dependent changes in5-HT transporter levels occur as a secondary response to Tph modulation.To further evaluate whether changes in SLC6A4expression are necessary for microbiota-mediated alterations in peripheral 5-HT,we tested the effects of microbiota manipulations on colon and serum5-HT in SLC6A4heterozygous(+/À)and complete (À/À)knockout(KO)mice.Depleting the microbiota via P42-P56antibiotic treatment(Reikvam et al.,2011)of SPF SLC6A4+/Àand SLC6A4À/Àmice effectively decreases colonic5-HT levels (Figures S4A and S4B),indicating that the microbiota is required for promoting gut5-HT in Slc6a4-deficient mice.Colonizing anti-biotic-treated SLC6A4+/Àand SLC6A4À/Àmice with Sp raises colon5-HT to levels seen in untreated SPF SLC6A4+/Àand SLC6A4À/Àmice(Figure S4A),demonstrating that Slc6a4is not required for conferring the effects of Sp on gut5-HT.Antibi-otic-induced decreases and Sp-induced increases in colon5-HT levels can be attributed to modulation of5-HT content in colonic ECs from SLC6A4+/Àand SLC6A4À/Àmice(Figure S4C).Similar effects of antibiotic treatment and Sp colonization are seen for serum5-HT in SLC6A4+/Àmice,whereas SLC6A4À/Àmice exhibit low to undetectable levels of serum5-HT,highlighting the dependence of platelets on Slc6a4-mediated5-HT uptake (Figure S4B).Taken together,these data support a role for Sp in promoting Tph1-mediated5-HT biosynthesis by colonic ECs,regulating both colon and serum levels of5-HT. Microbiota-Mediated Regulation of Host Serotonin Modulates Gastrointestinal MotilityIntestinal5-HT plays an important role in stimulating the enteric nervous system and GI function(Gershon and Tack,2007).To determine whether microbiota-dependent modulation of colonic 5-HT impacts GI motility,we colonized P42GF mice with Sp and then tested for GI transit and colonic neuronal activation at P56. Sp colonization ameliorates GF-associated abnormalities in GI motility,significantly decreasing total transit time and increasing the rate of fecal output in a Tph-dependent manner(Figures4A and4B).Similar effects are seen in SLC6A4+/Àand SLC6A4À/Àmice,where Sp colonization of antibiotic-treated mice restores GI transit time toward levels seen in untreated SPF SLC6A4+/Àand SLC6A4À/Àcontrols(Figure S4E).Consistent with deficits in GI motility,steady-state activation of5-HT receptor subtype4(5HT4)-expressing cells in the colonic submucosa and muscularis externa is decreased in GF mice compared to SPF controls,as measured by colocalized expres-sion of5HT4with the immediate early gene,c-fos(Figures4C–4E).Colonization of GF mice with Sp increases5HT4+c-fos+ staining to levels seen in SPF mice,and this effect is dependent on colonic Tph activity(Figures4C–4E),which aligns well with the understanding that Sp-induced elevations in colonic5-HT promote GI motility by activation of5HT4+enteric neurons (Mawe and Hoffman,2013).In addition,colonic activation of intrinsic afferent primary neurons(IPANs)of the myenteric plexus is decreased in GF mice(McVey Neufeld et al.,2013)and improved by colonization with Sp,as measured by colocalization of c-fos and the IPAN marker,calretinin(Calb2)(Figure4F).Inhib-iting Tph activity with PCPA decreases IPAN activation in Sp-colonized mice,suggesting that some IPAN responses to Sp depend on host5-HT synthesis(Figure4F).Altogether,these findings indicate that Sp-mediated increases in colonic5-HT biosynthesis are important for gut sensorimotor function. Microbiota-Mediated Regulation of Host Serotonin Modulates Platelet FunctionPlatelets uptake gut-derived5-HT and release it at sites of vessel injury to promote blood coagulation.To determine if microbiota-dependent modulation of colon(Figures1and3)and plasma (Figure S1A)5-HT impacts platelet function,we colonized P42 mice with Sp and then examined blood clotting,platelet activa-tion and platelet aggregation at P56.In a tail bleed assay(Liu et al.,2012),GF mice exhibit trending increases in time to cessa-tion of bleeding compared to SPF mice,suggesting impaired blood coagulation(Figure5A).Colonization of GF mice with Sp ameliorates abnormalities in bleeding time to levels seen in SPF controls,and this effect is attenuated by intrarectal admin-istration of PCPA(Figure5A),indicating that Sp-mediated im-provements in coagulation may be dependent on colonic Tph activity.Notably,the impact of acute colonic PCPA treatment on reducing5-HT content and5-HT-related functions in platelets may be tempered by the fact that mouse platelets have a lifespan of$4days(Odell and McDonald,1961).There were no signifi-cant differences between treatment groups in total platelet counts(Figure S5A).In light of inherent limitations of the tail bleed assay(Liu et al.,2012),we focused subsequent experiments particularly on platelet activity.Platelets isolated from GF mice display decreased activation in response to in vitro type Ifibrillar collagen stimulation, as measured by reduced surface expression of the activation markers granulophysin(CD63),P-selectin,and JON/A(integrin a IIb b3)(Figures5D–5F)(Ziu et al.,2012).Sp colonization of GF mice leads to partial restoration in the expression of platelet acti-vation markers,and this effect depends on colonic Tph activity (Figures5D–5F).Moreover,platelets isolated from GF mice exhibit impaired aggregation in response to in vitro collagen stimulation, as measured by decreased levels of high granularity,high mass aggregates detected by bothflow cytometry(De Cuyper et al., 2013;Nieswandt et al.,2004)(Figures5B,5C,S5C,and S5D) and imaging(Figure S5B).Colonization of GF mice with Sp re-stores levels of platelet aggregation to those seen in SPF mice. These effects of Sp on correcting impaired platelet aggregation are attenuated by colonic PCPA injection,indicating dependence on Tph activity.Overall,thesefindings suggest that Sp-mediated elevations in colonic5-HT,and thus platelet5-HT,promote platelet activation and aggregation relevant to hemostasis. Microbial Metabolites Mediate Effects of the Microbiota on Host SerotoninIn light of the important role for Sp in regulating5-HT-related in-testinal and platelet function,we aimed to identify specific micro-bial factors responsible for conferring the serotonergic effects of Sp.Based on ourfinding that Sp elevates5-HT particularly in colonic ECs(Figure2),we hypothesized that Sp promotes levels of a soluble factor that signals directly to ECs to modulate TPH1 expression and5-HT biosynthesis.To test this,we preparedfil-trates of total colonic luminal contents from Sp-colonized mice and controls and evaluated their effects on levels of5-HT in RIN14B chromaffin cell cultures(Nozawa et al.,2009).Relative268Cell161,264–276,April9,2015ª2015Elsevier Inc.to vehicle-treated controls,there is no significant effect of filtered colonic luminal contents from GF mice on levels of 5-HT released or TPH1expressed from RIN14B cells (Figures 6A and 6B).Filtered colonic luminal contents from SPF and Sp-colonized mice sufficiently induce 5-HT from RIN14B cells (Figure 6A),to levels comparable to those elicited by the calciumionophore,Figure 4.Microbiota-Mediated Regulation of Host Serotonin Modulates Gastrointestinal Motility(A)Total time for transit of orally administered carmine red solution through the GI tract (n =4–8).(B)Defecation rate as measured by number of fecal pellets produced relative to total transit time (n =4–8).(C)Representative images of c-fos and 5HT4colocalization in the colonic submucosa and muscularis externa (n =4–5mice/group).(D)Quantitation of total c-fos fluorescence intensity in the colonic submucosa and muscularis externa (n =4–5mice/group).(E)Quantitation of total 5HT4fluorescence intensity in the colonic submucosa and muscularis externa (n =4–5mice/group).(F)Quantitation and representative images of c-fos and calb2(calretinin)colocalization in the colonic submucosa and muscularis externa (n =5–8mice/group).Data are presented as mean ±SEM.*p <0.05,**p <0.01,***p <0.001,****p <0.0001.SPF,specific pathogen-free (conventionally-colonized);GF,germ-free;Sp,spore-forming bacteria;PCPA,para-chlorophenylalanine.See also Figure S4.Cell 161,264–276,April 9,2015ª2015Elsevier Inc.269ionomycin,as a positive control.TPH1expression is also ele-vated in chromaffin cells exposed to SPF and Sp luminal filtrates,suggesting increased 5-HT synthesis.This is in contrast to ionomycin,which stimulates 5-HT release,but has no effect on TPH1expression,from RIN14B cells.Importantly,these findings suggest that microbiota-mediated increases in gut 5-HT are conferred via direct signaling of a soluble,Sp-modulated factor to colonic ECs.We utilized metabolomic profiling to identify candidate Sp-dependent,5-HT-inducing molecules in feces from adult mice.Sp colonization of GF mice leads to statistically significant alter-ations in 75%of the 416metabolites detected,of which 76%are elevated and 24%are reduced,relative to vehicle-treated GF controls (Tables S1and S3).Similar changes are seen with hSp colonization,leading to co-clustering of Sp and hSp sam-ples by principal components analysis (PCA)(Figure 6C).ASF colonization has a mild effect,significantly modulating 50%of metabolites detected (66%increased,36%decreased)(Table S3),and forming a distinct but proximal cluster to GF controlsby PCA (Figure 6C).Postnatal conventionalization of GF mice with an SPF microbiota alters 66%of all metabolites detected (59%increased,41%decreased)(Table S3)and produces sub-stantial changes in the metabolome that are distinguishable from the effects of Sp,hSp,and ASF along PC2(Figure 6C).Notably,Sp,hSp,and SPF colonization results in similar shifts along PC1,compared to vehicle and ASF-treated controls,suggesting com-mon metabolic alterations among communities that similarly elevate peripheral 5-HT levels.Metabolomics profiling confirms that fecal 5-HT is commonly upregulated in the Sp,hSp,and SPF fecal metabolome and comparatively low in ASF and GF samples (Table S1).Simple linear regression reveals 83metabo-lites that co-vary with 5-HT (r 2R 0.25),47of which correlate positively and 36of which correlate negatively with 5-HT levels (Figure S6A;Table S4).To determine whether specific metabolites mediate the effects of Sp on 5-HT,we tested a subset of biochemicals that were commonly upregulated by Sp,hSp,and SPF,and that positively correlated with 5-HT levels (Figure S6A;Table S4),for their abilityG r a n u l o p h y s i n (C D 63) e x p r e s s i o n (m e a n i n t e n s i t y )+Sp.+Sp.PCPA:- +- +-SPFGFSPF+PCPAGF+Sp.+PCPAGF+Sp.B l e e d t i m e (s )+Sp.+Sp.PCPA:- +- +-P l a t e l e t a c t i v a t i o n (s t i m u l a t e d -u n s t i m u l a t e d c e l l s , %)+Sp.+Sp.PCPA:- +- +-**p=0.0576***A B DP -s e l e c t i n e x p r e s s i o n(m e a n i n t e n s i t y )2468+Sp.+Sp.PCPA:- +- +-**********J o n /A e x p r e s s i o n (m e a n i n t e n s i t y )51015+Sp.+Sp.PCPA:- +- +-*****n.s.- collagen+ collagen SPFGFSPF+PCPAGF+Sp.+PCPAGF+Sp.- collagen + collagenSPFGFSPF+PCPAGF+Sp.+PCPAGF+Sp.- collagen + collagen CE F SPF SPF+PCPA GF GF+Sp. GF+Sp.+PCPA+collagen+collagen+collagen+collagen+collagenSPFSPF+PCPAGFGF+Sp. GF+Sp.+PCPAF S C0.130.450.0830.10 0.2613.4 10.4 2.35 13.0 6.87Figure 5.Microbiota-Mediated Regulation of Host Serotonin Modulates Hemostasis(A)Time to cessation of bleeding in response to tail injury (n =7–16).(B)Platelet activation,as measured by percentage of large,high granularity (FSC high ,SSC high )events after collagen stimulation relative to unstimulated controls (n =3).(C)Representative flow cytometry plots of large,high granularity (FSC high ,SSC high )activated platelets after collagen stimulation (bottom),as compared to un-stimulated controls (top)(n =3).(D–F)Geometric mean fluorescence intensity of granulophysin (CD63)(D),P-selectin (E),and JON/A (integrin a IIb b 3)(F)expression in collagen-stimulated platelets (left).Representative histograms (right)of event count versus fluorescence intensity (log scale)for platelets treated with collagen (red line)or vehicle (blue line)(n =3).Data for platelet assays are representative of three independent trials with at least three mice in eachgroup.Data are presented as mean ±SEM.*p <0.05,**p <0.01,***p <0.001,****p <0.0001.n.s.,not statistically significant;SPF,specific pathogen-free (conventionally-colonized);GF,germ-free;Sp,spore-forming bacteria;PCPA,para-chlorophenylalanine.See also Figure S5.270Cell 161,264–276,April 9,2015ª2015Elsevier Inc.。